• Budget Impact Associated With The Implementation Of A Dtpa-Ipv-Hepb/Hib Hexa Vaccination Program In Slovenia

    Nov 1, 2016, 00:00

  • Construction of System Dynamics Model for Medical Care System of Japan

    Nov 1, 2016, 00:00

  • Trans-Pacific Partnership Agreement And Its Impact On Accessibility And Affordability Of Medicines- A Meta-Synthesis

    Nov 1, 2016, 00:00

  • Literature Review of Studies Evaluating Cost Effectiveness of Prostaglandins and ß-Blockers in Primary Open Angle Glaucoma Patients

    Nov 1, 2016, 00:00

  • Cost–Effectiveness of Different Strategies for Prevention of Venous Thromboembolism after Total Hip Replacement in China

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Sequential USE of ELF/ARFI Test Versus Biopsy to Assess Liver Fibrosis in Chronic HCV

    Nov 1, 2016, 00:00

  • The Road to Russian Pharmacoeconomics- Understanding the Drivers for Access to High-Value / Orphan Disease Drugs

    Nov 1, 2016, 00:00

  • When Cost Saving Technologies are Not Adopted Despite Evidence and Payer Recommendations – Intraoperative Fluid Management (IOFM) in the UK

    Nov 1, 2016, 00:00

  • Effects of A Chronic Obstructive Pulmonary Disease Integrated Care Pathway Programme in Singapore

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Evaluation of Acarizax® In Patients with House Dust Mites Induced Allergic Asthma And Allergic Rhinitis In Slovakia

    Nov 1, 2016, 00:00

  • Measuring Of The Uncertainty In Reimbursement System For Medicinal Products

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Insulin Degludec/Insulin Aspart (IDEGASP) Compared with Biphasic Insulin Aspart (BIASP 30) in Patients with Type 2 Diabetes Mellitus from a Mexican Healthcare Perspective

    Nov 1, 2016, 00:00

  • Assessment of Health Related Quality of Life (Hrqol) of Patients with Severe Mental Illness Attending Tertiary Care Public Hospitals of Quetta, Pakistan

    Nov 1, 2016, 00:00

  • Self-Efficacy And Health Behaviors Impact Quality Of Life Of Elderly Along Eastern Sea Coast Of Thailand 2015

    Nov 1, 2016, 00:00

  • Trend in HBA1C Levels Among Primary Care Diabetes Patients Admitted to a Tertiary Hospital in Singapore in 2013

    Nov 1, 2016, 00:00

  • Economic Evaluation of Everolimus as Second-Line Treatment of Metastatic Renal Cell Carcinoma in Greece

    Nov 1, 2016, 00:00

  • Predictors of Disease Progression in Mild Alzheimer’s Disease Dementia Patients – Results From the Geras Real World Cohort and Expedition Trials

    Nov 1, 2016, 00:00

  • Psoriatic Arthritis is Associated with A Greater Economic and Humanistic Burden Among Patients with Psoriasis- Results from A Multinational Physician and Patient Survey

    Nov 1, 2016, 00:00

  • Cost of Illness Study In Patients With Myasthenia Gravis Treated With Plasma Exchange Therapy In Belgium

    Nov 1, 2016, 00:00

  • The Patient Journey After A Diagnosis of Early/Locally Advanced Breast CA In Greece And Choice of Provider

    Nov 1, 2016, 00:00

  • Identifying Patient Reported Signs and Symptoms of Being Overweight and Obese

    Nov 1, 2016, 00:00

  • Use of Data-Mining to Perform a Real World Cost Analysis of Her2-Positive Breast Cancer In Iran

    Nov 1, 2016, 00:00

  • How Does Health Technology Assessment of Personalized Medicine for Non-Small Cell Lung Cancer Differ in France, Germany, and England?

    Nov 1, 2016, 00:00

  • Economic Burden of Stroke- A Systematic Review on Post-Stroke Care

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Brivaracetam Versus Other Antiepileptic Drugs Used as Adjunctive Treatment for Focal Seizures in the Uk- A Discrete Event Simulation Model

    Nov 1, 2016, 00:00

  • Health State Valuation in Sri Lanka Using the EQ-5D-3l; Precursor to Qaly Estimation in South Asia

    Nov 1, 2016, 00:00

  • Current Practice and Attitude Regarding off-Label Drug Use- A Survey of Oncology Practitioners

    Nov 1, 2016, 00:00

  • A Quantitative Analysis of Health Technology Assessment (HTA) Agencies for Attributes Driving Transparency of the Organization- Comparison of Six Asia-Pacific HTA Agencies

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Brentuximab Vedotin in Relapsed or Refractory Hodgkin's Lymphoma Following Autologous Stem Cell Transplant in Taiwan

    Nov 1, 2016, 00:00

  • What is the Most Cost-Effective Way to Set-Up Organised Cervical Cancer Screening in France? A Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • Hospitalized Patients with Schizophrenia In Portugal- Clinical Characterization and Costs

    Nov 1, 2016, 00:00

  • Assessment Of Knowledge And Practice Regarding Foot Care Of Diabetes Mellitus Patient In Tertiary Care Hospitals, Quetta, Pakistan

    Nov 1, 2016, 00:00

  • Prediction Of Costs Associated With The Hospital Management Of Hiv Patients In France Using An Advanced Data Mining Approach On The French Medical Information System Database

    Nov 1, 2016, 00:00

  • The Cost of Hypercholesterolaemia in Ireland

    Nov 1, 2016, 00:00

  • The 2016 US Payor Landscape- Results from a Survey of Medical and Pharmacy Directors on Formulary Management

    Nov 1, 2016, 00:00

  • Treatment Cost Estimation of Chronic Gastritis Caused by Helicobacter Pylori

    Nov 1, 2016, 00:00

  • Impact of Potential Drug Interactions in Cardiac Patients on Morbidity Risk- An Observational Prospective Approach

    Nov 1, 2016, 00:00

  • Trend Of Pharmacoeconomics And Health Outcome Studies In Turkey

    Nov 1, 2016, 00:00

  • Network Meta-Analysis To Evaluate The Efficacy of Ixekizumab In The Treatment of Moderate-To-Severe Psoriasis

    Nov 1, 2016, 00:00

  • Real World Data on the Adherance to the National Policy of Integrative and Complementary Practices in the Brazilian Unified Health System - The Acupuncture Case

    Nov 1, 2016, 00:00

  • Patients' Educational Background was Associated with the Validity and Reliability of a Health-Related Quality of Life Questionnaire

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Evolocumab in Patients with High Cardiovascular Risk in Spain

    Nov 1, 2016, 00:00

  • Impact of Comorbidities on the Cost of Depression Drug Therapy in General Practices in Germany

    Nov 1, 2016, 00:00

  • A Cost of Illness Study Evaluating The Burden of Wolfram Syndrome In The United Kingdom

    Nov 1, 2016, 00:00

  • Economic Benefits of Cpap Treatment for Obstructive Sleep Apnea in The Elderly

    Nov 1, 2016, 00:00

  • Real-World Comorbidities, Treatment Pattern and Cost of Patients with Acromegaly in Poland Based on Retrospective Analysis Of Administrative Claims Data

    Nov 1, 2016, 00:00

  • The Reduction Of Ceiling With The Eq-5d-5l Increases With Age In The General Adult Population

    Nov 1, 2016, 00:00

  • Quantification Of Quality Of Life Differences Due To Common Diseases In The Age Group 50+ In The United Kingdom

    Nov 1, 2016, 00:00

  • A Systematic Review of Tyrosine Kinase Inhibitors as First Line Treatment for Advanced Non Small Cell Lung Cancer

    Nov 1, 2016, 00:00

  • Multi-Criteria Assessment In HTA Process in the Czech Republic- the Role of Different Stakeholders Involvement and Impact on Appraisal of Drugs Including Orphans

    Nov 1, 2016, 00:00

  • The Impact Of Policy And Demographic Variables On Future Prescription Costs For A Publicly Funded Health Scheme In Ireland

    Nov 1, 2016, 00:00

  • Management of Children's Acute Diarrhea by Community Pharmacies in Five Towns of Ethiopia- Simulated Client Case

    Nov 1, 2016, 00:00

  • Beware the Impact of Discount Rates in the Assessment of HPV Vaccines

    Nov 1, 2016, 00:00

  • Understanding the Impact of Laboratory Performance on Outcomes in a Screening Population for Cardiovascular Disease in Taiwan

    Nov 1, 2016, 00:00

  • Screening Rate for Diabetic Retinopathy and Macular Edema in Patients with Diabetes and their Treatment Costs in the United Arab Emirates

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of Nivolumab Monotherapy for Metastatic Melanoma Treatment

    Nov 1, 2016, 00:00

  • Pharmacotherapy Consultations By Clinical Pharmacists To Improve Quality And Safe Use Of Medicines- An Experience From Tertiary Care Teaching Hospital

    Nov 1, 2016, 00:00

  • Determinants of Orphan Drug Prices in Italy and the UK

    Nov 1, 2016, 00:00

  • The Burden of Staple Line Interventions in Colorectal Surgery Europe

    Nov 1, 2016, 00:00

  • Diabetes Self-Management- Pharmacy Perspective

    Nov 1, 2016, 00:00

  • Resource Utilization and Costs of Resected Pancreatic Cancer Patients Receiving Neoadjuvant Treatment- Findings from a Real-World U.S. Population

    Nov 1, 2016, 00:00

  • Accelerated/Malignant Hypertension with a Diagnostic Ambugity- A Retrospective Cohort Study

    Nov 1, 2016, 00:00

  • Antithrombotic Treatment Pattern in Patients with Atrial Fibrillation in Italy Before and After Xaban/Dtis Launch- The Repair Study Cross-Sectional Results

    Nov 1, 2016, 00:00

  • THE IMPACT OF THE ECONOMIC CRISIS ON THE INCIDENCE AND INTENSITY OF CATASTROPHIC HEALTH PAYMENTS IN GREECE

    Nov 1, 2016, 00:00

  • Systemic Adverse Drug Reactions of Antihypertensive Agents

    Nov 1, 2016, 00:00

  • Need for Enhanced Glucose Screening in Pregnant Women in Indonesia

    Nov 1, 2016, 00:00

  • The European Social Preference Measurement (ESPM) Study- Conceptual Considerations and Implementation

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Type 2 Diabetes (T2DM) Treatment with Dapagliflozin as Add-On to Metformin in the Dominican Republic and Guatemala

    Nov 1, 2016, 00:00

  • Cost-Minimization Analysis Of Baofukang Versus Langyi In The Treatment Of Vvc

    Nov 1, 2016, 00:00

  • Increased Use of Effective Non-Cancer Drugs Following Removal of Benefit Caps Among Cancer Patients In Medicaid- A Quasi-Experimental Study

    Nov 1, 2016, 00:00

  • Increasing Efficiency of Pricing and Market Access Decisions By Cross Functional Interactions

    Nov 1, 2016, 00:00

  • The Cost of Asthma In Italy

    Nov 1, 2016, 00:00

  • Time and Cost of Hospitalization for Salvage Therapy Among Adults with Philadelhphia (PH)-Negative B-Cell Relapsed/Refractory (R/R) Acute Lymphoblastic Leukaemia (ALL) In Spain

    Nov 1, 2016, 00:00

  • Economic Evaluation of Diacerein, Diclofenac and Glucosamine for Osteoarthritis in China

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of Exercise for the Prevention of Cancer

    Nov 1, 2016, 00:00

  • Age and Gender Specific Trends in Acute Inpatient Stroke Incidence in Germany

    Nov 1, 2016, 00:00

  • Impact of Animal Testing on Mental Health of Researchers

    Nov 1, 2016, 00:00

  • How is Radiotherapy Reimbursed Across Europe? Results of The Health Economics in Radiation Oncology’s Survey

    Nov 1, 2016, 00:00

  • Survival and Resource use in The Treatment of Metastatic Renal Cell Carcinoma in Sweden- A Retrospective Analysis of Data from National Registries

    Nov 1, 2016, 00:00

  • Variation of Data Source Used for Baseline Population and for Natural Course of Alzheimer's Disease Progression in Model-Based Economic Evaluation of Treatment of AD

    Nov 1, 2016, 00:00

  • A Cost-Effectiveness Analysis of Pasireotide Long-Acting Compared To Continued Use of A First-Line Somatostatin Antagonist For The Treatment of Acromegaly In Sweden

    Nov 1, 2016, 00:00

  • Health Technology Assessment of the use Vaccines for Prevention Flu

    Nov 1, 2016, 00:00

  • Advanced Parkinson’s Disease In Stockholm County, Sweden – How Many Are They And What Are The Real-Life Health Care Costs?

    Nov 1, 2016, 00:00

  • Economic Analyses of Flair® and Fluency® Plus Endovascular Stent Grafts for the Treatment of Vascular Access Stenosis- A U.S. Hospital and Payer Perspective

    Nov 1, 2016, 00:00

  • Treatment of Osteochondral Fracture and Medial Patellofemoral Ligament Rupture After Patellar Dislocation

    Nov 1, 2016, 00:00

  • A Time Series Analysis of Social Insurance and Patient Costs of Reimbursed Medical AIDS in Hungary

    Nov 1, 2016, 00:00

  • The Association Between Loneliness and Healthcare Utilization Among Older Adults in Singapore

    Nov 1, 2016, 00:00

  • An Assessment of The Relative Efficacy of Sodium Glucose Co-Transporter 2 Inhibitors As Add-On To Metformin In Patients With Type 2 Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Investigating Influenza Vaccinations for Risk Groups in Ukraine

    Nov 1, 2016, 00:00

  • Consolidation of China's Two Basic Medical Insurance Programs- Understanding New Opportunities for Access

    Nov 1, 2016, 00:00

  • Adverse Events Associated with Intravenous Immunoglobulin in Thailand

    Nov 1, 2016, 00:00

  • Costs, Outcomes And Uses Of New Drugs- Drug Assessment Reports Vs Real World Data

    Nov 1, 2016, 00:00

  • Retrospective Database Study Describing Patient Characteristics And Resource Use in Swedish Patients Receiving Second Generation Long Acting Injection Antipsychotics

    Nov 1, 2016, 00:00

  • Iatrogenic Hypoglycaemia in the Elderly- An Analysis of Diabetic Medication Usage Patterns According to Age

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis For Treatment Of Parkinson’s Disease- A Systematic Review

    Nov 1, 2016, 00:00

  • Direct Medical Resource Utilization For Reoperation After Intramedullary Fixation of Pertrochanteric HIP Fractures

    Nov 1, 2016, 00:00

  • The Evolution of Risk-Sharing Agreements in the Process of Updating the National List of Health Services in Israel

    Nov 1, 2016, 00:00

  • ‘Severe Illness Insurance' in China- Impact of the New Coverage on Access to Health Care and Innovative Drugs

    Nov 1, 2016, 00:00

  • A Budget Impact Analysis to Estimate The Economic Consequences Of Introducing The Combination of Avastin + Tarceva for The Treatment of First Line Epidermal Growth Factor (EGFR) Metastatic Non-Small Cell Lung Cancer (NSCLC)

    Nov 1, 2016, 00:00

  • Advanced Therapy Medicinal Products (Atmps) In Europe 8 Years On- What Is The Path To Market Access So Far?

    Nov 1, 2016, 00:00

  • Evaluation of Health Care Costs and Utilization Patterns for Patients with Gout in Taiwan

    Nov 1, 2016, 00:00

  • Severe Sepsis In Adults- Impact of Diagnostic Coding on Hospital Resource Utilization

    Nov 1, 2016, 00:00

  • Multi-Criteria Decision Analysis to Evaluate the Femtosecond Laser-Assisted Cataract Surgery in Children

    Nov 1, 2016, 00:00

  • Nintedanib Plus Docetaxel as Second-Line Therapy in Patients with Non-Small-Cell Lung Cancer (NSCLC)- A Network Meta-Analysis vs. New Therapeutic Options

    Nov 1, 2016, 00:00

  • Which Types of Economic Evaluations are Considered by Health Technology Assessment Agencies?

    Nov 1, 2016, 00:00

  • Budget Impact Of Ulipristal Acetate 5mg In Pre-Operative Treatment Of Uterine Fibroids- An Analysis Based On Public Data On Hospital Stays In France

    Nov 1, 2016, 00:00

  • Using Evidence Reviews To Develop Focused Systematic Review Questions

    Nov 1, 2016, 00:00

  • Use of A Claims Database To Document The Use and Effectiveness of Oral Vinorelbine (NVBO) in A Real World Setting France

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Oral Fentanyl Formulations for Breakthrough Cancer Pain Treatment

    Nov 1, 2016, 00:00

  • Value of Improved Accuracy for Self-Monitoring of Blood Glucose Devices in Germany

    Nov 1, 2016, 00:00

  • Early Indicators of Patients with Major Depressive Disorder in Need of Highly Specialized Care- A Systematic Review

    Nov 1, 2016, 00:00

  • Work Productivity and use of Disease-Modifying Therapies in Multiple Sclerosis- Results From A Patient Survey Accessed Through Social Media

    Nov 1, 2016, 00:00

  • A Systematic Review On The Epidemiology of NRAS-Mutant Melanoma in Europe and Australia

    Nov 1, 2016, 00:00

  • Translation And Validation Of Condition-Specific Quality Of Life Pfdi-20 And Pfiq-7 Questionnaires For Women With Pelvic Floor Dysfunction In The Norwegian Context

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analyses of Pharmacologic Maintenance Treatment For Chronic Obstructive Pulmonary Disease- A Systematic Review

    Nov 1, 2016, 00:00

  • Determining The Clinical Practice And Resource Use Associated To The Diagnosis And Treatment Of Clostridium Difficile Infection In Mexico

    Nov 1, 2016, 00:00

  • Systematic Review of Eq-5d Based Health State Utility Values in Mulitple Myeloma

    Nov 1, 2016, 00:00

  • Virtual Planning and Patient-Specific Implants in Mandibular Reconstructionsurgery- A Micro-Costing Analysiss

    Nov 1, 2016, 00:00

  • Systematic Review of Health State Utilities Based on the Eq-5d in Studies of Lymphomas

    Nov 1, 2016, 00:00

  • The Impact of Rifaximin-A on Non-Elective Hospital Admission and Attendance Costs in Uk Patients with Hepatic Encephalopathy

    Nov 1, 2016, 00:00

  • Effects of Hbsag Positivity During Pregnancy on Adverse Maternal Outcomes- A Retrospective Database Analysis

    Nov 1, 2016, 00:00

  • Measures Taken By The Romanian Ministry Of Health For Better Access To Anti-Egfr Drugs

    Nov 1, 2016, 00:00

  • Annual Cost and Effects of Switching to Insulin Degludec from Other Basal Insulins- Evidence from Swedish Real-World Data

    Nov 1, 2016, 00:00

  • Comparative Efficacy of Time to Virologic Suppression in Treatment-Naive HIV-1 Patients- A Network Meta-Analysis of Longitudinal Data

    Nov 1, 2016, 00:00

  • Cardiovascular Safety of Saxagliptin In Patients With Type 2 Diabetes Mellitus- A Systematic Review And Meta-Analysis

    Nov 1, 2016, 00:00

  • Patient Reported Outcomes - Patient Satisfaction With Selected Characteristics of Rehabilitation Medical Devices - Usage, Acquisition, offer, Range And Quality

    Nov 1, 2016, 00:00

  • Comparison of Cost-Effectiveness Between Egfr-Tkis Therapy and Chemotherapy for Advanced Nsclc

    Nov 1, 2016, 00:00

  • Experiences And Attitudes Related To Screening of Patients Attended on A Colorectal Screening Pilot Program In Hungary

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis Of Daclatasvir With Asunaprevir Vs Paritaprevir/Ritonavir/Ombitasvir With Dasabuvir In Treatment Of Chronic Hepatitis C In The Russian Federation

    Nov 1, 2016, 00:00

  • Quality of Life (QOL) and Health Utility (UT) in Patients with Type 2 Diabetes Mellitus (DM2) Receiving Different Oral Hypoglycemic Therapy in a Real-World Setting

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Sacubitril/Valsartan (Formerly LCZ696) in Chronic Heart Failure Patients with Reduced Ejection Fraction - An Analysis for Switzerland

    Nov 1, 2016, 00:00

  • The Economic Value of Olmesartan for The Treatment of Hypertensive Patients- A Systematic Review

    Nov 1, 2016, 00:00

  • The Direct Cost Components in Chronic Thromboembolic Pulmonary Hypertension in Turkey- An Expert Panel Approach for Estimation of Costs

    Nov 1, 2016, 00:00

  • The Impact of Cancer Prevention and Treatment Policy on Increasing Incidence of Early-Stage Cancer in Taiwan

    Nov 1, 2016, 00:00

  • Eq-5d Studies In Nervous System Diseases In Eight Central And Eastern European Countries

    Nov 1, 2016, 00:00

  • Development of Antibiogram for Management of Aerobic Bacterial Infection in Diabetic Foot Ulcer

    Nov 1, 2016, 00:00

  • Secukinumab In The Management of Psoriatic Arthritis In Gree A Budget Impact Analysis

    Nov 1, 2016, 00:00

  • Analysing The Evolution of Cancer Drug Prices in France Since 2000

    Nov 1, 2016, 00:00

  • Mepolizumab For The Treatment of Chronic Asthma. A Meta-Analysis of Randomized Placebo-Controlled Trials

    Nov 1, 2016, 00:00

  • Choice of First Opioid Prescription and the Transitions from Acute to Long Term Opioid Use – Findings from Big Data

    Nov 1, 2016, 00:00

  • Cost-utility of nintedanib vs. Pirferidone in the treatment of idiopathic pulmonary fibrosis in spain

    Nov 1, 2016, 00:00

  • Preliminary Cost-Effectiveness Assessment of 3D Printed Anatomic Models for Congenital Heart Diseases

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of The use of Rivaroxaban in Treatment of Venous Thromboembolism in Spain

    Nov 1, 2016, 00:00

  • Cost Minimization Of Using Activated Prothrombin Complex Concentrate Versus Recombinant Activated Factor Vii In Patients With A Nd B Hemophilia In Presence Of Inhibitors

    Nov 1, 2016, 00:00

  • Potential Cost Savings of A Point-Of-Care Diagnostic Test Measuring Antipsychotic Plasma Levels for Treatment of Patients with Schizophrenia in Spain

    Nov 1, 2016, 00:00

  • The 2012 Updated Beers Criteria in Falls Related Hospitalization in Older Adults

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis Of Dimethyl Fumarate Versus Fingolimod And Teriflunomide In Patients With Relapsing-Remitting Multiple Sclerosis In Colombia

    Nov 1, 2016, 00:00

  • Comparative Effectiveness of Pharmacological Interventions For Preventing Migraine In Children And Adolescent- A Systematic Review and Network Meta-Analysis

    Nov 1, 2016, 00:00

  • Budget And Patient Access Analysis To Second Line Therapy Of Multiple Sclerosis In Bulgaria

    Nov 1, 2016, 00:00

  • Mapping The Policy Response To Breast Cancer In Asia

    Nov 1, 2016, 00:00

  • Response to Targeted Therapy and Healthcare Resource Utilization (HRU)- A European Retrospective Chart Review Study in Patients With HER2+ Metastatic Breast Cancer

    Nov 1, 2016, 00:00

  • Patient Access to High-Cost and High-Value Specialty Products in China- Review of Decisions From Zhejiang, Neimenggu, Shandong and Jiangxi

    Nov 1, 2016, 00:00

  • Antiasthmatic Drug Prescribing Pattern Assessment at Medical Reimbursement in Employees Health Care Facility of Banaras Hindu University

    Nov 1, 2016, 00:00

  • Extended Half-Life Coagulation Factor IX In Haemophilia B Prophylaxis- A Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • Business Intelligence for Detecting Possible Surgical Site Infections from Gallbladder Surgery (Chol) and Colon Surgery (Colo) in Ramathibodi Hospital, Thailand

    Nov 1, 2016, 00:00

  • Evaluating The Experiential Quality of Older People's Community Care- A Concept Mapping Approach To Instrument Design

    Nov 1, 2016, 00:00

  • Biosimilars And Reference Price Groups In Germany

    Nov 1, 2016, 00:00

  • A Systematic Review and Network Meta-Analysis of Intravitreal Aflibercept Injection Versus other Treatments For Macular Edema Secondary to Central Retinal Vein Occlusion

    Nov 1, 2016, 00:00

  • Treatment Patterns of ALK+ Non-Small Cell Lung Cancer in Western Europe

    Nov 1, 2016, 00:00

  • Cost Variations of Inpatient, Daycare and Outpatient Hysteroscopy in A Tertiary-Care Hospital in Malaysia

    Nov 1, 2016, 00:00

  • Economic Burden of Rheumatoid Arthritis In Italy- Possible Consequences on Early Rapidly Progressing Patients

    Nov 1, 2016, 00:00

  • Reconsidering Drugs Funded Via The Cancer Drugs Fund in England- What’s New This Time?

    Nov 1, 2016, 00:00

  • Timing of Insulin Injections Predicts Type 2 Diabetes Control and Adherence in a Multinational Sample

    Nov 1, 2016, 00:00

  • A Cost-Utility Analysis of the Risk Model-Guided Antiemetic Prophylaxis Versus Physician's Choice in Patients Receiving Chemotherapy for Early-Stage Breast Cancer- A Net-Benefit Regression Approach

    Nov 1, 2016, 00:00

  • Complementary and Alternative Medicine (CAM) Disclosure to the Health Care Providers- A Qualitative Insight from Malaysia Thalassemia Patients

    Nov 1, 2016, 00:00

  • A Trial-Based Euroqol Eq-5d Health Utility Analysis in Patients with Previously Treated Advanced Nsclc

    Nov 1, 2016, 00:00

  • Comparison of Direct Healthcare Costs Associated with Chronic Spontaneous /Idiopathic Urticaria in 7 Countries - Results from the Assure-CSU Study

    Nov 1, 2016, 00:00

  • A Systematic Review Comparing Studies of Cardiovascular Event Utilities by Geographic Region

    Nov 1, 2016, 00:00

  • PCSK9 Inhibitors May Improve Cardiovascular Outcomes- Can We Afford Them?

    Nov 1, 2016, 00:00

  • Change Management of Polypharmacy and Adheren The Experience of Eu Simpathy Program

    Nov 1, 2016, 00:00

  • Treatment Patterns of ALK+ Non-Small Cell Lung Cancer in Japan

    Nov 1, 2016, 00:00

  • Evaluation of Social Security Organization'(SSO) Regulations on Physician Prescribing Pattern in Iran in 2014

    Nov 1, 2016, 00:00

  • Cost Minimization Analysis of Peg-L-Asparginase Versus E.Coli L-Asparaginase in Pediatric Acute Lymphoblastic Leukemia (ALL) Patients- A Jordanian Perspective

    Nov 1, 2016, 00:00

  • Impact of Glucosamine on the Burden of Knee Osteoarthritis Over A 6 Month-Period in Fran An Observational Study

    Nov 1, 2016, 00:00

  • A Budget Impact Analysis of Secukinumab In The Management of Ankylosing Spondylitis In Greece

    Nov 1, 2016, 00:00

  • Overview on Epidemiological Data For Multiple Myeloma In Austria

    Nov 1, 2016, 00:00

  • How do Migraines Impact Patient Day-To-Day life? An Exploratory Analysis of Patient Reported Data From The Patientslikeme Community

    Nov 1, 2016, 00:00

  • Current Trends in Methods of Pharmacoeconomic Studies of Cancer Therapies in China

    Nov 1, 2016, 00:00

  • The Relationship Between Regret In Patient Decision-Making During The Clinical Process And Patient Factors—Tests Based On The Japanese Version Of The Decision Regret Scale(Drs)—

    Nov 1, 2016, 00:00

  • Transcatheter Aortic Valve Implantation For Inoperable Severe Aortic Stenosis - A Meta-Analysis

    Nov 1, 2016, 00:00

  • Suggestion on Critical Illness Insurance in China

    Nov 1, 2016, 00:00

  • Efficiency in Use of Lensx Vs Phacoemulsification Surgery for Cataract Treatment- Results from a Global Observational Study

    Nov 1, 2016, 00:00

  • Patient Individual Therapy as Appropriate Comparator in Amnog-Dossiers in The Field of Oncology- Status Quo and Strategic Implications For Pharmaceutical Companies

    Nov 1, 2016, 00:00

  • Effectiveness of Clinical Pharmacist Intervention on Direct Medical Cost in Chronic Obstructive Pulmonary Disorder Patients - A Randomized Controlled Study

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Selexipag Versus Inhaled Iloprost In The Treatment of Pulmonary Arterial Hypertension (PAH) In Sweden

    Nov 1, 2016, 00:00

  • The Adoption of Roles by Primary Care Providers During Implementation of The New Chronic Disease Guidelines in Urban Mongolia- A Qualitative Study

    Nov 1, 2016, 00:00

  • Feasibility of Matching-Adjusted Indirect Comparison (MAIC) of Omalizumab (OMA) vs. Mepolizumab (Mepo) in Moderate-to-Severe Asthma

    Nov 1, 2016, 00:00

  • Assessment of Patient Preferences in the Treatment of Relapsing-Remitting Multiple Sclerosis in Public and Private Systems in Latin America

    Nov 1, 2016, 00:00

  • Cost Effectiveness Analysis Of Different Health Policies Based On The Second Generation Daa-Ifn Free Regimens In An Italian Population

    Nov 1, 2016, 00:00

  • Good Cop, Bad Cop; G-BA and Iqwig in Clinical Outcome Evaluations

    Nov 1, 2016, 00:00

  • Trend Towards Longer Time to Reimbursement in Oncological Medicines in Finland 2005-2015

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis Of Daclatasvir With Asunaprevir In Treatment Of Chronic Hepatitis C In The Russian Federation

    Nov 1, 2016, 00:00

  • Understanding the Policy-Relevant Portion of the Efficient Frontier in Screening Interventions- The Importance of Comparator Strategies

    Nov 1, 2016, 00:00

  • Are Allocation Preferences In Health Care Consistent With A Particular Definition Of Severity? Results From A Random-Sample Survey Of Norwegians

    Nov 1, 2016, 00:00

  • Prescription Trend in Antihypertensive Drugs in Mumbai And Suburbs- A Survey

    Nov 1, 2016, 00:00

  • Cost Effectivess Analysis for Combination of Aspirin and Warfarin Versus Warfarin Alone in Patients with Heart Valve Prosthesis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Surgical Excision Vs Mohs Micrographic Surgery for Non-Melanoma Skin Cancer

    Nov 1, 2016, 00:00

  • A Patient Level Simulation Model

    Nov 1, 2016, 00:00

  • Key Drivers of HTA Decisions for “Life-Changing” Drugs

    Nov 1, 2016, 00:00

  • Effective Use of Long-Term Healthcare In Chile- Are International Migrants At Disadvantage of Universal Health Coverage

    Nov 1, 2016, 00:00

  • The Impact of Surgical Professional Education- A Review of Clinical and Economic Outcomes

    Nov 1, 2016, 00:00

  • Inflammatory Back Pain- Impact on Working Hours, and Quality of Life at 12 Months

    Nov 1, 2016, 00:00

  • Review of Insulin Listing in the National Drug Formulary of Malaysia

    Nov 1, 2016, 00:00

  • Drug Pricing And Reimbursement Processes In Algeria

    Nov 1, 2016, 00:00

  • Heparin and Related Substances for Treating Diabetic Foot Ulcers

    Nov 1, 2016, 00:00

  • Perioperative Therapies Reducing Homologous Transfusions During Cardiovascular Surgery- A Network Meta-Analysis of Randomized Controlled Trials

    Nov 1, 2016, 00:00

  • Cost-of-Illness of Metastatic Gastroenteropancreatic Neuroendocrine Tumours In Sweden – A Register-Linkage Population-Based Study

    Nov 1, 2016, 00:00

  • Mapping the Irritable Bowel Syndrome Quality of Life Measure (IBS-QOL) to EQ-5D in Patients with Irritable Bowel Syndrome with Diarrhoea (IBS-D)

    Nov 1, 2016, 00:00

  • Oab in Poland - This is Time for A Change

    Nov 1, 2016, 00:00

  • Cost of Sorafenib for Russian Government Drug Provision Program

    Nov 1, 2016, 00:00

  • Sleeping Pills Use Among Adults in Israel

    Nov 1, 2016, 00:00

  • A Study on Drug Utilization and Drug Related Proplems Among Anti-Ulcer Patiend Admitted in Teaching Hospital

    Nov 1, 2016, 00:00

  • Patterns of Index Biologic Drug Registrations To A Pharmacovigilance Register of Psoriasis Patients

    Nov 1, 2016, 00:00

  • Aligned and Flexible? A Comparative Review of SMC and Nice Decision-Making

    Nov 1, 2016, 00:00

  • Use of Internet and Reliability of Information Obtained Online Concerning Medication Risks/Safety- Perceptions of Consumers in the U.S

    Nov 1, 2016, 00:00

  • The Hector Study- Health Economics Study of Codeine And Tramadol Non-Responders – A Sub Population Analysis

    Nov 1, 2016, 00:00

  • HCV- Treat Ratio and Governance Footprints. Analysis of Regional Differences in Italy

    Nov 1, 2016, 00:00

  • Viability Of Using Electronic Medical Records From European Countries As Data In Novelty (A Novel Observational Longitudinal Study Of Patients With Asthma And/Or Copd)

    Nov 1, 2016, 00:00

  • The Impact On Societal Burden Of Changed Uptake Of Hormonal Treatments

    Nov 1, 2016, 00:00

  • Influence of Perceived Risk on Willingness to Pay for Diagnosis of Cardiovascular Diseases

    Nov 1, 2016, 00:00

  • The Role and Impact of Evidence Review Group Analyses in the Nice Single Technology Assessment (STA) Process

    Nov 1, 2016, 00:00

  • The mothif study. Costs of Clotting Factors In Haemophilia A And B- A Review From The Berhlingo Database In Seven Comprehensive Health Care Centres In France

    Nov 1, 2016, 00:00

  • Impact and Importance of Real World Data in Asia- A Physician's Perspective

    Nov 1, 2016, 00:00

  • Status of Orphan Drugs and Reimbursement Recommendations and Decisions in Analysed European Countries

    Nov 1, 2016, 00:00

  • Characteristics Of A Patient Population Recruited Using Social Media (Facebook) Compared With Newspaper Advertising (Daily Mail)

    Nov 1, 2016, 00:00

  • The Normal Reimbursement Procedure Of The Pharmaceutical Submissions Between 2013 And 2015 In Hungary - Needs And Results

    Nov 1, 2016, 00:00

  • Development of a Responder Definition for the Migraine Physical Function Impact Diary (MPFID)

    Nov 1, 2016, 00:00

  • Job Burnout Predictors In Community Pharmacists In Serbia

    Nov 1, 2016, 00:00

  • Budgetary Impact Analysis of Reimbursement Varenicline in the Smoking Cessation Treatment of Patients with Major Depression in Spain

    Nov 1, 2016, 00:00

  • How to Handle Data Quality Issues in EQ-5D-5L Valuation Studies. The Spanish Case

    Nov 1, 2016, 00:00

  • Do Health Technology Agencies Accept Methods for Dealing with Treatment Switching and Immature OS Data?

    Nov 1, 2016, 00:00

  • Characteristics, Resources Utilization And Safety Profile of Patients with Acute Pain- A European Real World Evidence Study

    Nov 1, 2016, 00:00

  • Comparative Effectiveness of Platinum Plus Paclitaxel Versus Platinum Plus Cyclophosphamide Among Patients with Early-Stage Ovarian Cancer in Taiwan

    Nov 1, 2016, 00:00

  • Making Sense of Clinical Data Reported in Secondary Conditions- The Epidemiology and Clinical Burden of Hyperglycaemia

    Nov 1, 2016, 00:00

  • Comparative Effectiveness Analysis for Smoking Cessation Medications and Relapse

    Nov 1, 2016, 00:00

  • Pharmacoutilization In Patients Suffering From Non-Valvular Atrial Fibrillation

    Nov 1, 2016, 00:00

  • To what Extent are The Learnings from The Introduction of Biosimilars in Inflammatory Diseases Transferable to The Future Introduction of Biosimilars in Oncology?

    Nov 1, 2016, 00:00

  • The Economic Impact of Tobacco Smoking In The Latin-American Healthcare Systems- A Study Conducted In Seven Countries And Its Extrapolation At The Regional Level

    Nov 1, 2016, 00:00

  • Comprehensive Evaluation of The Disease Burden Associated with Hemophilia A In China

    Nov 1, 2016, 00:00

  • Fore! Sweeping Generalisations do not Bowl Over all Cultures… Cultural Adaptation in the Kidney Disease Quality of Life Questionnaire

    Nov 1, 2016, 00:00

  • Directly Eliciting Personal Utility Functions From A Convenience Sample Of 30 Health Outcomes Professionals- A Pilot Study

    Nov 1, 2016, 00:00

  • Assure-Csu- Resource Use and Economic Burden in Patients with Refractory Chronic Spontaneous/Idiopathic Urticaria in Italy

    Nov 1, 2016, 00:00

  • Assessment of Biosimilar Landscape in Korea, Malaysia, Singapore and Taiwan

    Nov 1, 2016, 00:00

  • A Pubmed Based Search on Cost Effectiveness and Health-Related Quality of Life Studies with Respect to Complementary and Alternative Medicines

    Nov 1, 2016, 00:00

  • Budget Impact Analysis Of Ceftolozane/Tazobactam (Zerbaxa) For The Treatment Of Complicated Intra-Abdominal Infections And Complicated Urinary Tract Infections In The Italian Setting

    Nov 1, 2016, 00:00

  • Health Resource Use and Cost Under Pay on Fee and Case-Based Payment in Hospitalized Patients with Chronic Obstructive Pulmonary Disease in China

    Nov 1, 2016, 00:00

  • Direct Medical Cost and Healthcare Resource Utilization in Elderly Patients with Type 2 Diabetes Mellitus Among Insured Urban Population in China

    Nov 1, 2016, 00:00

  • Assessment Of Various Factors Influencing Quality Of Life In Pcos Patients Of Northern Telangana Region Of India

    Nov 1, 2016, 00:00

  • Glatiramer Acetate (Ga) Results in Significant Reductions in Annualized Relapse Rate (Arr) and Protective Effect on Disibiltiy Progression- Results From a Network Meta-Analysis

    Nov 1, 2016, 00:00

  • The Cancer Drugs Fund- The Evolving Assessment Process

    Nov 1, 2016, 00:00

  • International Reference Pricing Across EU

    Nov 1, 2016, 00:00

  • A Preliminary Cost-Utility Analysis of Non-Invasive Vagus Nerve Stimulation Therapy in Patients Suffering with Headache and Functional Disorder Multi-Morbidity

    Nov 1, 2016, 00:00

  • Gestational Diabetes Screening for Chinese Women- A Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • A Cross-National Comparison Of The Effect Of Age And Gender On Health-Related Quality Of Life (Hrql)

    Nov 1, 2016, 00:00

  • Simulating Patient-Level Profiles To Capture Patient Heterogeneity In Health-Economic Applications

    Nov 1, 2016, 00:00

  • Drivers in HTA Decision-Making for Cholesterol Lowering PCSK9 Inhibitors

    Nov 1, 2016, 00:00

  • Application of A Value Framework Based on Multiple Criteria Decision Analysis in the Context of Health Technology Assessment- A Series of Case Studies with Decision Makers Across European Countries

    Nov 1, 2016, 00:00

  • Which Medical Device for Urinary Incontinence Provides Patient The Higher Quality of Life?

    Nov 1, 2016, 00:00

  • EQ-5D Studies in Diseases of The Circulatory System in Eight Central and Eastern European Countries

    Nov 1, 2016, 00:00

  • Impact of Inadequate Insulin Resuspension (IIR) on Clinical, Patient And Economic Outcomes- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Granulocyte Colony-Stimulating Factor (G-Csf) as Adjunctive Therapy in Cancer Patients with Established Febrile Neutropenia

    Nov 1, 2016, 00:00

  • Comparative Analysis of The Guidelines for Conducting Hta in Poland and Bulgaria

    Nov 1, 2016, 00:00

  • Comparative Effectiveness of Treatment Strategies For Multiple Myeloma in Elderly Patients- A Network Meta-Analysis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Oxaliplatin Plus Fluorouracil/Leucovorin (Folfox4) Compared to Sorafenib for Treatment of Advanced Hepatocellular Carcinoma Patients in China

    Nov 1, 2016, 00:00

  • Will Stem Cells For Heart Failure Be The Next Sofosbuvir Issue?

    Nov 1, 2016, 00:00

  • Cost Analysis of Levofloxacin 750mg During 5 Days Vs Levofloxacin 500mg During 10 Days for the Treatment of Comunity-Acquired Pneumonia Under the Brazilian Public Hospital Perspective

    Nov 1, 2016, 00:00

  • The Use of ‘Off The Shelf’ Informative Prior Distributions In Random Effect Network Meta-Analysis Models

    Nov 1, 2016, 00:00

  • Chemotherapy, Cytokines and Cancer-Related Fatigue- A Systematic Review of Quantitative Studies in 1312 Patients

    Nov 1, 2016, 00:00

  • Biosimilar Infliximab- Feedback After A Nine Months Experience Of Their Use In The 37 Public Hospitals Of Paris

    Nov 1, 2016, 00:00

  • Spill Over Economic Impacts on Families of Children Receiving Hospital-Based Care

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Apixaban Versus Warfarin in Chinese Patients with Non-Valvular Atrial Fibrillation

    Nov 1, 2016, 00:00

  • Kidney-Related Complications Are Associated With Worse Outcomes Among Hospitalized Children With Autosomal Dominant Polycystic Kidney Disease In The US

    Nov 1, 2016, 00:00

  • Economic Evaluation of Protease Inhibitors for the Treatment of Patients with Genotype 1 Chronic Hepatitis C in Kazakhstan

    Nov 1, 2016, 00:00

  • Costs of Perennial Allergic Rhinitis And Asthma Increase with Level of Severity And Level of Disease Control

    Nov 1, 2016, 00:00

  • Cost Analysis of Voriconazole Versus Liposomal Amphotericin B And Caspofungin For Primary Therapy of Invasive Aspergillosis Among High-Risk Hematologic Cancer Patients In Lebanon

    Nov 1, 2016, 00:00

  • A Prospective Analysis of Adverse Drug Reaction in A Tertiary Care Hospital

    Nov 1, 2016, 00:00

  • Facing Challenges for a Cost Comparison of Day Surgical and Inpatient Varicose Vein Surgery

    Nov 1, 2016, 00:00

  • Association Between Stages of Change and Medication Adherence Among Diabetic Patients in a Primary Health Care Setting in Qatar- A Preliminary Study

    Nov 1, 2016, 00:00

  • The Cost-Effectiveness of Bariatric Surgery in Germany, France, Italy and the United Kingdom

    Nov 1, 2016, 00:00

  • Review of Multicriteria Decision Analysis Application for Decision-Making in Oncology

    Nov 1, 2016, 00:00

  • Cost And Resource Utilization Among Multiple Sclerosis Patients With Increasing Disability In Latin America

    Nov 1, 2016, 00:00

  • Multi-Criteria Decision Analysis (MCDA)- Common Tools for Different Needs Supporting Healthcare Decision Making in Spain

    Nov 1, 2016, 00:00

  • The Added Value of Real-World Evidence to Connect Disconnected Networks for Network Meta-Analysis- A Case Study in Rheumatoid Arthritis

    Nov 1, 2016, 00:00

  • Implications of Price Erosion of Docetaxel After Loss of Exclusivity on Cost-Effectivess

    Nov 1, 2016, 00:00

  • Using A Smartphone Based Self-Management Platform To Support Medication Adherence And Clinical Consultation In Parkinson’s Disease Results From The Smart-PD Randomised Controlled Trial

    Nov 1, 2016, 00:00

  • Impact of National Orphan Drug Policy and Reimbursement Mechanisms Over the Implementation of Managed Entry Agreements in Select Asia-Pacific Countries

    Nov 1, 2016, 00:00

  • Economic Analysis of Evarrest Sealant Matrix Compared with Standard of Care in Severe Soft Tissue Surgical Bleeding- A France Hospital Perspective

    Nov 1, 2016, 00:00

  • Evaluating The Cost-Benefit of A Cognitive Assessment and Training Program Across A Smart City Population in The UK

    Nov 1, 2016, 00:00

  • The Impact of Inflammatory Bowel Disease on Work Productivity- Comparison of A Real-World Sample Of Patients With Crohn's Disease And Ulcerative Colitis

    Nov 1, 2016, 00:00

  • The Evaluation Health Education to Elevate Correct Medication Knowledge and Ability in Community

    Nov 1, 2016, 00:00

  • Hepatitis C – Real World Effectiveness of HCV Treatment in Poland

    Nov 1, 2016, 00:00

  • Proqolid Database- Evolution Of Content, Structure, And Functionalities (2012-2016) - Integration In Eprovide, A New Online Platform Dedicated To Clinical Outcome Assessment (Coa) Research

    Nov 1, 2016, 00:00

  • Cholesterol Management in the US

    Nov 1, 2016, 00:00

  • Cost of Treatment of Actinic Keratosis on the Face/Scalp in Sweden

    Nov 1, 2016, 00:00

  • Exploring Determinants Of Polypharmacy In The Elderly Population In Austria

    Nov 1, 2016, 00:00

  • Direct Costs Of Epilepsy In Turkey- A Panel Approach

    Nov 1, 2016, 00:00

  • Burden of Diverticular Disease- An Observational Analysis Based on Italian Real World Data

    Nov 1, 2016, 00:00

  • Using Subpopulation Treatment Effect Pattern Plot to Identify More Efficient Resource Allocation Policies

    Nov 1, 2016, 00:00

  • Criteria Driving Values Assessments in Multiple Sclerosis Medicines

    Nov 1, 2016, 00:00

  • In-Licensing as a Business Strategy for Pharmaceutical Companies- A Framework for the Nigerian Industry

    Nov 1, 2016, 00:00

  • Utilization And Cost Of Antimicrobials Used In Medicine And Surgery Departments Of A Tertiary Care Teaching Hospital

    Nov 1, 2016, 00:00

  • Zinforo (Ceftaroline Fosamil) Versus other Empiric Antibiotics for Moderate-to-Severe Community Acquired Pneumonia (CAP) In Adults- a Network Meta-Analysis

    Nov 1, 2016, 00:00

  • A Clinical Literature Review of Coronary Artery Calcification and Current Treatment Outcomes in Japan

    Nov 1, 2016, 00:00

  • Is there Evidence of a Difference Between Willingness to Pay and Willingness to Accept Thresholds? A Review of Nice Technology Appraisals

    Nov 1, 2016, 00:00

  • An Update of Real-World Cost-Utility Evaluation of Multiple Myeloma Treatments In Stem Cells Transplant Patients

    Nov 1, 2016, 00:00

  • Spatial Distribution of the Total Number of Medical Devices in Turkey- A Classification Analysis

    Nov 1, 2016, 00:00

  • key Drivers for Market Penetration of Biosimilars in Europe

    Nov 1, 2016, 00:00

  • The Accuracy of Patient Self Report in Measuring Continuity of Care in Australia

    Nov 1, 2016, 00:00

  • Understanding Methodological Differences Between and The Appropriate Application of Oncology Value Frameworks in Healthcare Decision-Making

    Nov 1, 2016, 00:00

  • Statistical Models to Predict Indication of Respiratory Patients Between Asthma and COPD

    Nov 1, 2016, 00:00

  • Medication Adherence And Persistance In Type 2 Diabetes Mellitus (T2dm)- Patients Perspective In Ths Spanish Health Care System

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Different Biologic Agents For Ankylosing Spondylitis Treatment In Russia

    Nov 1, 2016, 00:00

  • Knowledge and Perception of Medicine, Dentistry and Pharmacy Students of Malaysian University Regarding Ebola Virus Disease (EVD)

    Nov 1, 2016, 00:00

  • Innovation - A Value For Health And Growth, An International Study On Market Access Stakes For Therapeutic Innovation

    Nov 1, 2016, 00:00

  • Access To Innovative Medicines In The Czech Republic- Length Of Price And Reimbursement (PR) Procedures

    Nov 1, 2016, 00:00

  • Pharmacists Manpower Analysis In Years 2006-2014 At Minstery Of Health In Saudi Arabia

    Nov 1, 2016, 00:00

  • Indirect Costs Genereted By Absenteeism Associated with Sclerosis Multiplex In Poland

    Nov 1, 2016, 00:00

  • A Parallel Observational and Prospective Study on Pharmacoeconomic Analysis and Prescribing Pattern of Antibiotics in Infectious Diseases

    Nov 1, 2016, 00:00

  • Treatment Comparative Effectiveness In Rare Diseases- The Case of Transthyretin Familial Amyloid Polyneuropathy Survival

    Nov 1, 2016, 00:00

  • Real Life Data Demonstrate Significant Reductions In HBA1C In T2DM Patients Switching From Other Insulins To Insulin Degludec

    Nov 1, 2016, 00:00

  • Launching Novel Antibiotics- Access Opportunities and Resistance in European Markets

    Nov 1, 2016, 00:00

  • Humanistic and Economic Outcomes of Pharmacist-Provided Medication Reviews in the Elderly- A Systematic Review and Meta-Analysis

    Nov 1, 2016, 00:00

  • Burden of Illness in Patients with Elevated High-Sensitivity C-Reactive Protein Levels and a History of Myocardial Infarction- A Targeted Literature Review

    Nov 1, 2016, 00:00

  • Attribute Development Using Continuous Stakeholder Engagement to Prioritize Treatment Decisions- A Framework for Patient-Centered Research

    Sep 1, 2016, 00:00

  • Economic Impact of Integrated Care Models for Patients with Chronic Diseases- A Systematic Review

    Sep 1, 2016, 00:00

  • A Comprehensive Algorithm for Approval of Health Technologies With, Without, or Only in Research- The Key Principles for Informing Coverage Decisions

    Sep 1, 2016, 00:00

  • The Capability Approach- A Critical Review of Its Application in Health Economics

    Sep 1, 2016, 00:00

  • Comparison of Daily versus Weekly Recording of Gastroesophageal Reflux Disease Symptoms in Patients with a Partial Response to Proton Pump Inhibitor Therapy

    Sep 1, 2016, 00:00

  • Did It Matter That the Cancer Drugs Fund Was Not NICE? A Retrospective Review

    Sep 1, 2016, 00:00

  • Response to Editorial- Estimating Health-State Utility for Economic Models in Clinical Studies- An ISPOR Good Research Practices Task Force Report

    Sep 1, 2016, 00:00

  • When Future Change Matters- Modeling Future Price and Diffusion in Health Technology Assessments of Medical Devices

    Sep 1, 2016, 00:00

  • A Systematic Review of Health Economic Evaluation Studies Using the Patient’s Perspective

    Sep 1, 2016, 00:00

  • A Framework for Incorporating Patient Preferences Regarding Benefits and Risks into Regulatory Assessment of Medical Technologies

    Sep 1, 2016, 00:00

  • Which Questionnaire Should Be Used to Measure Quality-of-Life Utilities in Patients with Acute Leukemia? An Evaluation of the Validity and Interpretability of the EQ-5D-5L and Preference-Based Questionnaires Derived from the EORTC QLQ-C30

    Sep 1, 2016, 00:00

  • International Experiences in Quantitative Benefit-Risk Analysis to Support Regulatory Decisions

    Sep 1, 2016, 00:00

  • Estimating Health-State Utility for Economic Models in Clinical Studies- An ISPOR Good Research Practices Task Force Report

    Sep 1, 2016, 00:00

  • Impact of Treatment Subsidies and Cash Payouts on Treatment Choices at the End of Life

    Sep 1, 2016, 00:00

  • Decision Modeling for Cost-Utility Analysis

    Sep 1, 2016, 00:00

  • Developing a Patient-Centered Benefit-Risk Survey- A Community-Engaged Process

    Sep 1, 2016, 00:00

  • Cost-Effectiveness of Rotavirus Vaccination in France—Accounting for Indirect Protection

    Sep 1, 2016, 00:00

  • Adherence to Self-Care Behaviors among Patients with Type 2 Diabetes—The Role of Risk Preferences

    Sep 1, 2016, 00:00

  • First and Foremost Battle the Virus- Eliciting Patient Preferences in Antiviral Therapy for Hepatitis C Using a Discrete Choice Experiment

    Sep 1, 2016, 00:00

  • Table of Contents

    Sep 1, 2016, 00:00

  • Increasing Patient Involvement in Drug Development

    Sep 1, 2016, 00:00

  • Financing a Cure for Diabetes in a Multipayer Environment

    Sep 1, 2016, 00:00

  • Copyright/Subscription

    Sep 1, 2016, 00:00

  • Instructions for Authors

    Sep 1, 2016, 00:00

  • Patient Preferences in Regulatory Benefit-Risk Assessments- A US Perspective

    Sep 1, 2016, 00:00

  • Measuring High-Risk Patients’ Preferences for Pharmacogenetic Testing to Reduce Severe Adverse Drug Reaction- A Discrete Choice Experiment

    Sep 1, 2016, 00:00

  • Regulatory Decision Making in Canada—Exploring New Frontiers in Patient Involvement

    Sep 1, 2016, 00:00

  • From the Co-Editors-In-Chief

    Sep 1, 2016, 00:00

  • Patient-Focused Benefit-Risk Analysis to Inform Regulatory Decisions- The European Union Perspective

    Sep 1, 2016, 00:00

  • Patient Heterogeneity in Health Economic Decision Models for Chronic Obstructive Pulmonary Disease- Are Current Models Suitable to Evaluate Personalized Medicine?

    Sep 1, 2016, 00:00

  • Measuring Health and Broader Well-Being Benefits in the Context of Opiate Dependence- The Psychometric Performance of the ICECAP-A and the EQ-5D-5L

    Sep 1, 2016, 00:00

  • Development and Validation of Algorithms to Identify Statin Intolerance in a US Administrative Database

    Sep 1, 2016, 00:00

  • Clinical Guidelines- A NICE Way to Introduce Cost-Effectiveness Considerations?

    Jul 1, 2016, 00:00

  • Health or Happiness? A Note on Trading Off Health and Happiness in Rationing Decisions

    Jul 1, 2016, 00:00

  • Power and Sample Size Calculations in Clinical Trials with Patient-Reported Outcomes under Equal and Unequal Group Sizes Based on Graded Response Model- A Simulation Study

    Jul 1, 2016, 00:00

  • Development of Seasonal Influenza Vaccination Recommendations- Relevance and Influence of the Evidence on the Decision-Making Process in France and The Netherlands

    Jul 1, 2016, 00:00

  • Breakthrough Cancer Pain- Ten Commandments

    Jul 1, 2016, 00:00

  • A Framework for Developing the Structure of Public Health Economic Models

    Jul 1, 2016, 00:00

  • Performance and Validation of Chronic Liver Disease Questionnaire-Hepatitis C Version (CLDQ-HCV) in Clinical Trials of Patients with Chronic Hepatitis C

    Jul 1, 2016, 00:00

  • Instructions for Authors

    Jul 1, 2016, 00:00

  • Cost-Utility Analysis of Long-Acting Beta Agonists versus Leukotriene Receptor Antagonists in Older Adults with Persistent Asthma Receiving Concomitant Inhaled Corticosteroid Therapy

    Jul 1, 2016, 00:00

  • A PROMIS Measure of Neuropathic Pain Quality

    Jul 1, 2016, 00:00

  • Predicting the Burden of Revision Knee Arthroplasty- Simulation of a 20-Year Horizon

    Jul 1, 2016, 00:00

  • A Tale of Two Thresholds- A Framework for Prioritization within the Cancer Drugs Fund

    Jul 1, 2016, 00:00

  • Cost-Effectiveness and Clinical Practice Guidelines- Have We Reached a Tipping Point?—An Overview

    Jul 1, 2016, 00:00

  • On the Estimation of the Cost-Effectiveness Threshold- Why, What, How?

    Jul 1, 2016, 00:00

  • Cholinesterase Inhibitor Utilization- The Impact of Provincial Drug Policy on Discontinuation

    Jul 1, 2016, 00:00

  • Table of Contents

    Jul 1, 2016, 00:00

  • Copyright/Subscription

    Jul 1, 2016, 00:00

  • About the Reliability of the Critical Review to Investigate the Generalizability of Economic Evaluations Conducted in Italy

    Jul 1, 2016, 00:00

  • Challenges in Measuring Cost and Value in Oncology- Making It Personal

    Jul 1, 2016, 00:00

  • Health Technology Assessment for Molecular Diagnostics- Practices, Challenges, and Recommendations from the Medical Devices and Diagnostics Special Interest Group

    Jul 1, 2016, 00:00

  • How Many Alternatives Can Be Ranked? A Comparison of the Paired Comparison and Ranking Methods

    Jul 1, 2016, 00:00

  • Estimating the Medical Care Costs of Obesity in the United States- Systematic Review, Meta-Analysis, and Empirical Analysis

    Jul 1, 2016, 00:00

  • Comparison of Value Set Based on DCE and/or TTO Data- Scoring for EQ-5D-5L Health States in Japan

    Jul 1, 2016, 00:00

  • Evaluating the Importance of Heterogeneity of Treatment Effect- Variation in Patient Utilities Can Influence Choice of the “Optimal” Oral Anticoagulant for Atrial Fibrillation

    Jul 1, 2016, 00:00

  • From the Co-Editors-In-Chief

    Jul 1, 2016, 00:00

  • Considering Cost-Effectiveness in Cardiology Clinical Guidelines- Progress and Prospects

    Jul 1, 2016, 00:00

  • Cost-Effectiveness of Eltrombopag versus Romiplostim for the Treatment of Chronic Immune Thrombocytopenia in England and Wales

    Jul 1, 2016, 00:00

  • Association between Time Since Cancer Diagnosis and Health-Related Quality of Life- A Population-Level Analysis

    Jul 1, 2016, 00:00

  • Economic and Public Health Impacts of Policies Restricting Access to Hepatitis C Treatment for Medicaid Patients

    Jun 1, 2016, 00:00

  • Using the Evaluative Linguistic Framework for Questionnaires to Assess Comprehensibility of Self-Report Health Questionnaires

    Jun 1, 2016, 00:00

  • Does the Introduction of the Ranking Task in Valuation Studies Improve Data Quality and Reduce Inconsistencies? The Case of the EQ-5D-5L

    Jun 1, 2016, 00:00

  • Physician and Patient Preferences for Nonvalvular Atrial Fibrillation Therapies

    Jun 1, 2016, 00:00

  • Budget Impact of Increasing Market Share of Patient Self-Testing and Patient Self-Management in Anticoagulation

    Jun 1, 2016, 00:00

  • Editorial on Statistical Methods for the Analysis of Discrete Choice Experiments

    Jun 1, 2016, 00:00

  • Health Utilities for Multiple Sclerosis

    Jun 1, 2016, 00:00

  • Mapping the COPD Assessment Test onto EQ-5D

    Jun 1, 2016, 00:00

  • Statistical Methods for the Analysis of Discrete Choice Experiments: A Report of the ISPOR Conjoint Analysis Good Research Practices Task Force

    Jun 1, 2016, 00:00

  • A Randomized Controlled Trial of Two Distinct Shared Decision-Making Aids for Hip and Knee Osteoarthritis in an Ethnically Diverse Patient Population

    Jun 1, 2016, 00:00

  • Copyright/Subscription

    Jun 1, 2016, 00:00

  • Assessing Asthma Symptoms in Adolescents and Adults- Qualitative Research Supporting Development of the Asthma Daily Symptom Diary

    Jun 1, 2016, 00:00

  • Response to Letter to the Editor by Dr. Garattini

    Jun 1, 2016, 00:00

  • Cost-Effectiveness Model for Chemoimmunotherapy Options in Patients with Previously Untreated Chronic Lymphocytic Leukemia Unsuitable for Full-Dose Fludarabine-Based Therapy

    Jun 1, 2016, 00:00

  • Open Access Publication in Value in Health

    Jun 1, 2016, 00:00

  • Societal Costs of First-Incident Ischemic Stroke in Patients with Atrial Fibrillation—A Danish Nationwide Registry Study

    Jun 1, 2016, 00:00

  • The Impact of Patient-Centered versus Didactic Education Programs in Chronic Patients by Severity- The Case of Type 2 Diabetes Mellitus

    Jun 1, 2016, 00:00
  • «
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76 (current)
  • 77
  • 78
  • 79
  • 80
  • »